Concepedia

Kimberly Tipton

KT

7

Publications

478

Citations

7

H-Index

2002

Active since

Affiliations

University of California, San Francisco(Current)

Howard Hughes Medical Institute

Bristol-Myers Squibb (United States)

CytomX Therapeutics (United States)

Kimberly Tipton is an author at University of California, San Francisco specializing in medicine, tumor immunology, and tumor immunity.

ORCID

Top concepts

Publications per year

2002–2022

7

Publications

7

In Vivo Monitoring of the Prion Replication Cycle Reveals a Critical Role for Sis1 in Delivering Substrates to Hsp104

Kimberly Tipton, Katherine Joanne Verges, Jonathan S. Weissman · Molecular Cell · 2008 · 173 citations · Full text

, , +12

Directed Evolution of Substrate-Optimized GroEL/S Chaperonins

Jue D. Wang, Christophe Herman, Kimberly Tipton et al. · Cell · 2002 · 148 citations · Full text

,

<i>Shigella dysenteriae</i>ShuS Promotes Utilization of Heme as an Iron Source and Protects against Heme Toxicity

Elizabeth E. Wyckoff, Gregory F. Lopreato, Kimberly Tipton et al. · Journal of Bacteriology · 2005 · 69 citations · Full text

Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic

Iñaki Etxeberría, Elixabet Bolaños, Álvaro Teijeira et al. · Proceedings of the National Academy of Sciences · 2021 · 34 citations · Full text

, , +17

Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate

Shweta Singh, Laura Serwer, Amy DuPage et al. · Molecular Cancer Therapeutics · 2022 · 26 citations · Full text

Rows per page

1–5 of 7